Add like
Add dislike
Add to saved papers

Biosynthesised silver and copper nanoformulation as foliar spray to control bird's eye spot disease in tea plantations.

IET Nanobiotechnology 2017 December
Tea leaves have economic importance in preparation of the popular beverage of the world "tea". Bird's eye spot disease of tea leaves creates significant revenue loss in tea trade of many tea plant cultivating countries. Management of this disease by silver (AgNps) and copper (CuNps) nanoparticles that are biosynthesised by efficient antagonists was studied. The biocontrol agents like Pseudomonas fluorescens, Trichoderma atroviride and Streptomyces sannanensis were evaluated for nanoparticle synthesis against Cercospora theae isolates namely KC10, MC24 and VC38. Initially, the freshly prepared extracellular AgNps showed high disease control (59.42 - 79.76%), but the stability of antagonistic property in stored nanoparticles were significantly high in CuNps (58.71 - 73.81%). Greenhouse studies on various treatments imposed also showed reduced disease incidence percentage of 13.4, 7.57 and 10.11% when treated with CuNps synthesized by P. fluorescens, T. atroviride and S. sannanensis respectively. Various treatment schedule in fields suggested the use of [email protected] ppm for highest yield (3743 kg/ha) with 66.1% disease prevention. The results suggest the use of biosynthesised CuNps using Streptomyces sannanensis for controlling the tea plant pathogens causing foliar disease with higher stability in releasing the antagonistic activity during sporadic disease incidence of bird's eye spot disease in tea plants.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app